JUBILANT PHARMOVA
|
|
BOM : 530019 NSE : JUBLPHARMA | |
LT :
Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive] Debt : High |
Updated: |
ST :
Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Downward Pledged Shares : None or < 25% |
Apr 07,2025 |
Price(EOD): ₹ 884.35
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
|
Pharmaceuticals & Drugs |
MCap: ₹ 14,087.70 Cr |
Industry Peers & Returns | 1W | 1M | 1Y |
JUBILANT PHARMOVA | -3.3% | -1.3% | 60.6% |
SUN PHARMACEUTICAL INDUSTRIES | -1.7% | 5.5% | 5.4% |
DIVIS LABORATORIES | -5.2% | -4.6% | 49% |
CIPLA | -4.2% | -2.4% | -3.8% |
TORRENT PHARMACEUTICALS | 1.6% | 8.4% | 26.9% |
DR REDDYS LABORATORIES | -5.5% | -3.4% | -9.4% |
MANKIND PHARMA | -3.2% | 3.9% | 5% |
ZYDUS LIFESCIENCES | -4.6% | -5.6% | -12.2% |
LUPIN | -1.7% | -4.3% | 22.8% |
FUNDAMENTAL ANALYSIS OF JUBILANT PHARMOVA
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
VALUATION OF JUBILANT PHARMOVA
Ratio | Consolidated | |
---|---|---|
P/E P/B P/S |
22.71
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 620.20 Cr
[Latest Qtr - Dec2024 - Consolidated Results ] 2.6
P/B Calculated based on Book Value of Rs 5,419.40 Cr
[Latest Year - Mar2024 - Consolidated Results ] 1.99
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 7,064.30 Cr
[Latest Qtr - Dec2024 - Consolidated Results ] |
|
Financial Ratios → |
Model | Discount(-)/ Premium(+) |
---|---|
EV/EBIDTA EV/Sales Price/Sales |
170% 46% 50% |
SHARE PRICE MOMENTUM OF JUBILANT PHARMOVA
JUBILANT PHARMOVA vs SENSEX
DEBT OF JUBILANT PHARMOVA
Year | Debt/Equity ratio | |
---|---|---|
Standalone | Consolidated | |
2024 2023 2022 Avg_3yrs |
0.15 0.13 0.07 0.12 |
0.63 0.63 0.55 0.6 |
[Last Annual Data : Mar2024]
|
||
Financial Ratios → |
PLEDGED PROMOTER SHARES OF JUBILANT PHARMOVA
Pledged Promoter Shares |
0 % | |
---|---|---|
As on : Dec2024 | ||
If less than 25% | Good |
|
If between 25% and 50% | Neutral | |
If greater than 50% | Bad | |
Shareholding Pattern → |
QTRLY RESULTS OF JUBILANT PHARMOVA
Consolidated | Q-o-Q | Y-o-Y |
---|---|---|
Revenue Op Profit Profit Before Tax Profit After Tax |
3.96% -0.69% -9.48% -1.56% |
8.62% 31.83% 48.81% 89.49% |
QtrlyTrend |
2 | |
Latest Qtr: Dec2024 | ||
Quarterly Result Analysis → |
JUBILANT PHARMOVA related INDICES
BSE Indices | 1W | 1M | 1Y |
---|---|---|---|
BSE ALLCAP | NA | 7% | 4.8% |
BSE MIDSMALLCAP | -2.6% | 6% | 2.3% |
BSE 500 SHARIAH | -4.7% | 1.4% | -5.7% |
BSE HEALTHCARE | -5.2% | 1.8% | 10.7% |
BSE 500 | -5.7% | 0.9% | -2.6% |
NSE Indices | 1W | 1M | 1Y |
---|---|---|---|
NIFTY 500 EQUAL WEIGHT | -5.7% | 1.5% | NA |
NIFTY TOTAL MARKET | -5.8% | 0.9% | -2.3% |
NIFTY 500 | -5.8% | 0.9% | -2.3% |
NIFTY MIDSMALL HEALTHCARE | -5.8% | 2% | 16% |
NIFTY500 MULTICAP 50:25:25 | -5.8% | 1.1% | -2.4% |
You may also like the below Video Courses
FAQ about JUBILANT PHARMOVA
Is JUBILANT PHARMOVA good for long term investment?
As on Apr 07,2025, the Fundamentals of JUBILANT PHARMOVA look Average and hence you may wait for the results to improve to invest for long term ! See Financial Performance of JUBILANT PHARMOVA . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!Is JUBILANT PHARMOVA UnderValued or OverValued?
As on Apr 07,2025, JUBILANT PHARMOVA is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!What is the Intrinsic Value of JUBILANT PHARMOVA ?
As on Apr 07,2025, the Intrinsic Value of JUBILANT PHARMOVA is Rs. 591.32 estimated based on Median of the 3 historical models.Fair Value [Median EV / EBIDTA Model] : Rs. 327.31
Fair Value [Median EV / Sales Model] : Rs. 604.17
Fair Value [Median Price / Sales Model] : Rs. 591.32
Estimated Median Fair Value of JUBILANT PHARMOVA : Rs. 591.32
The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.